Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 7/20 | 0.52 |
| ▸ | MEN1 | O00255 | 6/20 | 0.52 |
| ▸ | BLM | P54132 | 3/20 | 0.52 |
| ▸ | PPARG | P37231 | 3/20 | 0.52 |
| ▸ | NR1I2 | O75469 | 2/20 | 0.52 |
| ▸ | AGTR2 | P50052 | 1/20 | 0.52 |
| ▸ | PCNA | P12004 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 6/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.47 |
| ▸ | MAPT | P10636 | 3/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.47 |
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.47 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | HTR1A | P08908 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5574192 | 1.00 | KMT2A (0.52) | KMT2AMEN1BLMPPARGNR1I2 | |
| SCHEMBL230513 | 1.00 | KMT2A (0.52) | KMT2AMEN1BLMPPARGNR1I2 | |
| SCHEMBL6350388 | 0.99 | KMT2A (0.51) | KMT2AMEN1BLMPPARGNR1I2 | |
| SCHEMBL16390915 | 0.88 | KMT2A (0.47) | KMT2AMEN1BLMPPARGNR1I2 | |
| SCHEMBL10495232 | 0.87 | BLM (0.41) | KMT2AMEN1BLMPPARGNR1I2 | |
| SCHEMBL10537170 | 0.87 | BLM (0.41) | KMT2AMEN1BLMPPARGNR1I2 | |
| Hydrochloric Acid SCHEMBL10529768 | 0.86 | BLM (0.41) | KMT2AMEN1BLMPPARGNR1I2 | |
| SCHEMBL836727 | 0.85 | KMT2A (0.61) | KMT2AMEN1BLMPPARGNR1I2 | |
| SCHEMBL4355962 | 0.85 | KMT2A (0.61) | KMT2AMEN1BLMPPARGNR1I2 | |
| SCHEMBL10938099 | 0.85 | KMT2A (0.61) | KMT2AMEN1BLMPPARGNR1I2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 795 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260002120-A1 | METHODS AND COMPOSITIONS FOR SPINAL CORD CELLS | CEDARS-SINAI MEDICAL CENTER (US) | 2026-01-01 | — | — | US | claimed |
| US-20250376659-A1 | DERIVATION OF SOMATOTROPHS FROM STEM CELLS AND USES THEREOF | MEMORIAL SLOAN-KETTERING CANCER CENTER (US) | 2025-12-11 | — | — | US | claimed |
| US-20240374694-A1 | METHOD FOR MANUFACTURING A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF SPINAL CORD INJURY | SUPINE THERAPEUTICS CO., LTD. (KR) | 2024-11-14 | — | — | US | claimed |
| CN-118718106-A | Tissue engineering skin based on pluripotent stem cells and preparation method thereof | 中科合肥技术创新工程院 | 2024-10-01 | — | — | CN | claimed |
| CN-115996710-B | Pharmaceutical composition comprising L-triiodothyronine (T3) for the treatment of hypoxia and sepsis | 联康药业克雷恩特塞提斯制药实验室有限责任公司 | 2024-06-28 | — | — | CN | claimed |
| US-20240189224-A1 | IMPLANTABLE DEVICES FOR DRUG DELIVERY WITH REDUCED BURST RELEASE | FEDSON, INC. (US) | 2024-06-13 | — | — | US | claimed |
| US-20240076620-A1 | PRODUCTION OF SKELETAL MUSCLE CELLS AND SKELETAL MUSCLE TISSUE FROM PLURIPOTENT STEM CELLS | GEORG-AUGUST-UNIVERSITÄT GÖTTINGEN STIFTUNG ÖFFENTLICHEN RECHTS, UNIVERSITÄTSMEDIZIN (DE) | 2024-03-07 | — | — | US | claimed |
| US-20230372589-A1 | INTERPOSITIONAL IMPLANT FOR GROWTH PLATE INJURY | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2023-11-23 | — | — | US | claimed |
| CN-116745402-A | Methods and cell structures | 莫纳什大学 | 2023-09-12 | — | — | CN | claimed |
| CN-116323918-A | Mass production of human pluripotent stem cell-derived cardiac stromal cells | 乔治-奥古斯特-哥廷根大学公法大学医学基金会 | 2023-06-23 | — | — | CN | claimed |
| EP-0466909-B1 | THYROID HORMONE FOR CARDIAC TREATMENT | BRITISH TECH GROUP USA (US) | 1995-06-28 | — | — | EP | claimed |
| EP-0424954-B1 | Pharmaceutical composition for treatment of osteoporosis | NIPPON ZOKI PHARMACEUTICAL CO (JP) | 1994-04-27 | — | — | EP | claimed |
| US-5116828-A | Estrogen and thyroid hormone | NIPPON ZOKI PHARMACEUTICAL CO., LTD. (JP) | 1992-05-26 | — | — | US | claimed |
| US-H1018-H | Immunological method for the determination of free substances having hapten properties | HENNING BERLIN GMBH CHEMIE- UND PHARMAWERK (DE) | 1992-01-07 | — | — | US | claimed |
| EP-0424954-A1 | Pharmaceutical composition for treatment of osteoporosis | NIPPON ZOKI PHARMACEUTICAL CO. LTD. (JP) | 1991-05-02 | — | — | EP | claimed |
| US-4521511-A | SUBSTITUTED PHENOLS AS ACCELERATOR | ENZYME TECHNOLOGY COMPANY (US) | 1985-06-04 | — | — | US | claimed |
| EP-0103784-A2 | Catalyzed colorimetric and fluorometric substrates for peroxidase enzyme determinations | ENZYME TECHNOLOGY COMPANY (US) | 1984-03-28 | — | — | EP | claimed |
| US-4110076-A | IN UNEXTRACTED BLOOD SERUM | MALLINCKRODT, INC. (US) | 1978-08-29 | — | — | US | claimed |
| US-4014651-A | RADIOACTIVE LABEL ON THYROID HORMONE | MALLINCKRODT, INC. (US) | 1977-03-29 | — | — | US | claimed |
| US-3938953-A | Process and device for blood examination using substances labelled with radioactive nuclides | HOECHST AKTIENGESELLSCHAFT (DT) | 1976-02-17 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260002120-A1 | METHODS AND COMPOSITIONS FOR SPINAL CORD CELLS | POU2F1, KDR, POU2F2 | KMT2A 3618/4885MEN1 3973/4885BLM 4762/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.